Follow us:


CALIPSO: revolutionizing the management of bioproduction processes in healthcare

Paris (France) – September 16th, 2021 – Sanofi, Capgemini, Ypso-Facto, GPC Bio, CEA, CentralSupelec announce the launch of the project CALIPSO !

  • by Ypso-Facto
  • September 16, 2021
  A structuring R&D project for French medical research, financed and coordinated by a consortium of high-profile industrial and public actors. An essential mobilisation to accelerate access to new treatments at an acceptable cost, to ensure France’s competitiveness and its health independence...

Read more

WEBINAR - Associating digital tools and QbD to speed-up process development

  • by Ypso-Facto
  • March 26, 2021
Regulatory bodies, including the FDA and EMA, are strongly promoting the implementation of QbD: a science and risk-based approach to drug development and manufacturing to increase the success rate, process robustness and eventually product quality. In the meantime, different practitioners are a bit...

Read more

WEBINAR - Using predictive digital tools to speed-up process development

A few simple and hopefully rational considerations.

  • by Ypso-Facto
  • March 11, 2021
In terms of digitalization, the biotech industries are quite significantly behind others, like the automotive or aeronautical industries, possibly because the digital tools available are not very well suited to their needs. Roger-Marc explains how numerical tools can support process development by...

Read more

WEBINAR - Deuterium in the 21st century, use in medicinal chemistry and synthetic methods

  • by Ypso-Facto
  • March 09, 2021
Ninety years after its discovery, Deuterium is in the spotlight. Since the beginning of the 21st century, a number of biotechnology companies have successfully explored its potential in drug candidates and generated intellectual property. This approach has been ‘’validated’’ by the first approval...

Read more

Process comparison in Ypso-Proxima: EASY by Sanofi vs. classical mAb purification process

Technical and economic evaluation to reduce Cost of Goods

Thomas Prouzeau, Jerome Pezzini, and Benoit Mothes

  • by Ypso-Facto
  • January 15, 2021
During the last years, alternatives to Protein A purification in mAb downstream processing have raised substantial interest. In parallel, the pharmaceutical industry has a growing need for reliable tools supporting process development and rational decision-making. This article [1] illustrates the...

Read more

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information